Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Front-Loaded Survival Benefit of RIC in DLBCL: Consistent Early Response Across Racial Groups in 95,531 Patients

ABCL - 1368

Front-Loaded Survival Benefit of RIC in DLBCL: Consistent Early Response Across Racial Groups in 95,531 Patients

Shivam Patel

Poster Presenter: Shivam Patel

Thumbnail for Frontline ABVD Chemotherapy Outcomes in Hodgkin Lymphoma in a Resource-Limited Setting: Real-World Survival and Prognostic Factors

HL - 582

Frontline ABVD Chemotherapy Outcomes in Hodgkin Lymphoma in a Resource-Limited Setting: Real-World Survival and Prognostic Factors

Hammad Javed

Poster Presenter: Hammad Javed

Thumbnail for Frontline Antifungal Prophylaxis With Dose-Adjusted Venetoclax Combinations in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Previous 1...52 53 54 55 56 57 58...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 1609

Frontline Antifungal Prophylaxis With Dose-Adjusted Venetoclax Combinations in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Ana Paula Orgambide-Aguilar

Poster Presenter: Ana Paula Orgambide-Aguilar

Thumbnail for Frontline BTK Inhibitor Strategies in Mantle Cell Lymphoma: A Phase 3 Network Meta-Analysis With Cross-Trial Synthesis Across Transplant-Eligible and -Ineligible Populations

MCL - 522

Frontline BTK Inhibitor Strategies in Mantle Cell Lymphoma: A Phase 3 Network Meta-Analysis With Cross-Trial Synthesis Across Transplant-Eligible and -Ineligible Populations

Sameer Bhimani

Poster Presenter: Sameer Bhimani

Thumbnail for Frontline Systemic Therapeutic Patterns and Outcomes in Rosai-Dorfman Disease: A Multicenter Retrospective Analysis

MPN - 1474

Frontline Systemic Therapeutic Patterns and Outcomes in Rosai-Dorfman Disease: A Multicenter Retrospective Analysis

Aishwarya Pradeep

Poster Presenter: Aishwarya Pradeep

$Thumbnail for Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis$

MM - 1441

Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis

Faiza Khalid

Poster Presenter: Faiza Khalid

Thumbnail for Gender-based Differences in Presentation and Outcomes of Mantle Cell Lymphoma: A 25-Year Institutional Experience

MCL - 577

Gender-based Differences in Presentation and Outcomes of Mantle Cell Lymphoma: A 25-Year Institutional Experience

Pallawi Torka

Poster Presenter: Pallawi Torka

$Thumbnail for Generalizability Gaps in BCMA- and GPRC5D-Directed Immunotherapy Trials for Relapsed/Refractory Multiple Myeloma: A Trial-Level Eligibility Analysis$

MM - 813

Generalizability Gaps in BCMA- and GPRC5D-Directed Immunotherapy Trials for Relapsed/Refractory Multiple Myeloma: A Trial-Level Eligibility Analysis

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

Thumbnail for Genetic Analysis of Triple-Negative Myeloproliferative Neoplasms Using Whole-Exome Sequencing

MPN - 491

Genetic Analysis of Triple-Negative Myeloproliferative Neoplasms Using Whole-Exome Sequencing

Munira Borhany

Poster Presenter: Munira Borhany

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors